Emerging Trends in Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: A Focus on Liver Transplant Candidates
ABSTRACT Background Immunotherapy has emerged as a promising neoadjuvant strategy for hepatocellular carcinoma (HCC), with growing evidence supporting its role in tumor downstaging and enabling radical resection. Liver transplantation remains a curative option for HCC, and the integration of neoadju...
Saved in:
| Main Authors: | Dongdong Yu, Hao Chen, Lidong Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Cancer Reports |
| Online Access: | https://doi.org/10.1002/cnr2.70244 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunotherapy for hepatocellular carcinoma in liver transplant patients (Literature review)
by: I. A. Dzhanyan, et al.
Published: (2023-09-01) -
Adding dendritic cell-immunotherapy for post-transplant hepatocellular carcinoma recurrence
by: Wei-Chen Lee, et al.
Published: (2025-08-01) -
Managing hepatocellular carcinoma recurrence after liver transplantation: emerging role of immune checkpoint inhibitors
by: Mohammad Saeid Rezaee-Zavareh, et al.
Published: (2025-07-01) -
Long-term results of liver transplantation for hepatocellular carcinoma
by: M. Sh. Khubutia, et al.
Published: (2018-08-01) -
Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis
by: O. D. Olisov, et al.
Published: (2018-09-01)